Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
11.61
+1.01 (9.53%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Armata Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
423671174514856
Upgrade
Market Cap Growth
454.96%-42.84%161.30%-69.80%165.90%72.90%
Upgrade
Enterprise Value
5861902075914953
Upgrade
Last Close Price
11.611.853.241.245.482.98
Upgrade
PS Ratio
83.6312.9425.868.1433.1867.83
Upgrade
PB Ratio
--1.39-3.651.245.852.96
Upgrade
P/TBV Ratio
---1.386.783.63
Upgrade
EV/Sales Ratio
115.8736.7545.6610.6933.2364.37
Upgrade
Debt / Equity Ratio
-1.86-2.63-3.751.351.500.70
Upgrade
Net Debt / Equity Ratio
-1.70-2.44-3.330.941.090.19
Upgrade
Net Debt / EBITDA Ratio
-5.11-2.85-2.68-0.94-1.22-0.17
Upgrade
Net Debt / FCF Ratio
-5.94-2.97-1.92-0.98-1.11-0.18
Upgrade
Asset Turnover
0.050.060.050.070.080.03
Upgrade
Quick Ratio
0.110.211.030.942.761.52
Upgrade
Current Ratio
0.120.231.161.093.121.62
Upgrade
Return on Equity (ROE)
---3439.35%-120.10%-104.65%-132.62%
Upgrade
Return on Assets (ROA)
-22.20%-28.70%-26.32%-27.89%-27.25%-41.53%
Upgrade
Return on Capital Employed (ROCE)
66.10%-111.10%-49.90%-52.10%-36.70%-65.80%
Upgrade
Earnings Yield
-11.10%-28.26%-58.95%-82.37%-15.60%-39.73%
Upgrade
FCF Yield
-6.49%-58.90%-47.45%-77.40%-16.76%-34.20%
Upgrade
Buyback Yield / Dilution
-0.16%-63.71%-5.20%-42.27%-46.84%-104.93%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.